These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 20624692)

  • 21. BAG-S53P4 as bone graft extender and antimicrobial activity against gentamicin- and vancomycin-resistant bacteria.
    Bortolin M; Romanò CL; Bidossi A; Vecchi E; Mattina R; Drago L
    Future Microbiol; 2018 Apr; 13():525-533. PubMed ID: 29521127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical Applications of S53P4 Bioactive Glass in Bone Healing and Osteomyelitic Treatment: A Literature Review.
    van Gestel NA; Geurts J; Hulsen DJ; van Rietbergen B; Hofmann S; Arts JJ
    Biomed Res Int; 2015; 2015():684826. PubMed ID: 26504821
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of an antibiotic-impregnated, osteoconductive, bioabsorbable bone substitute in the treatment of infected long bone defects: early results of a prospective trial.
    McKee MD; Wild LM; Schemitsch EH; Waddell JP
    J Orthop Trauma; 2002 Oct; 16(9):622-7. PubMed ID: 12368641
    [TBL] [Abstract][Full Text] [Related]  

  • 24. BAG-S53P4 as an additive to bone allografts: A laboratory study using an uniaxial compression test.
    Putzer D; Fuchs J; Coraça-Huber D; Christoph A; Liebensteiner M; Nogler M
    J Orthop Res; 2015 Dec; 33(12):1875-9. PubMed ID: 26016590
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Posterolateral spondylodesis using bioactive glass S53P4 and autogenous bone in instrumented unstable lumbar spine burst fractures. A prospective 10-year follow-up study.
    Rantakokko J; Frantzén JP; Heinänen J; Kajander S; Kotilainen E; Gullichsen E; Lindfors NC
    Scand J Surg; 2012; 101(1):66-71. PubMed ID: 22414472
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antimicrobial activity and resistance selection of different bioglass S53P4 formulations against multidrug resistant strains.
    Drago L; De Vecchi E; Bortolin M; Toscano M; Mattina R; Romanò CL
    Future Microbiol; 2015; 10(8):1293-9. PubMed ID: 26228640
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of ciprofloxacin-releasing bioabsorbable osteoconductive bone defect filler for treatment of experimental osteomyelitis due to Staphylococcus aureus.
    Koort JK; Mäkinen TJ; Suokas E; Veiranto M; Jalava J; Knuuti J; Törmälä P; Aro HT
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1502-8. PubMed ID: 15793132
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibiofilm agents against MDR bacterial strains: is bioactive glass BAG-S53P4 also effective?
    Bortolin M; De Vecchi E; Romanò CL; Toscano M; Mattina R; Drago L
    J Antimicrob Chemother; 2016 Jan; 71(1):123-7. PubMed ID: 26462989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mid-term clinical results of chronic cavitary long bone osteomyelitis treatment using S53P4 bioactive glass: a multi-center study.
    Van Vugt TAG; Heidotting J; Arts JJ; Ploegmakers JJW; Jutte PC; Geurts JAP
    J Bone Jt Infect; 2021; 6(9):413-421. PubMed ID: 34804776
    [No Abstract]   [Full Text] [Related]  

  • 30. S53P4 BIOACTIVE GLASS PUTTY IN THE LOCAL TREATMENT OF CAVITARY CHRONIC OSTEOMYELITIS.
    Reis GNBD; Cuba GT; Targa WHC; Miras PSC; Bongiovanni JC; Salles MJ; Reis FBD; Dell'aquila AM
    Acta Ortop Bras; 2023; 31(1):e258453. PubMed ID: 36844131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bioactive glass S53P4 and autograft bone in treatment of depressed tibial plateau fractures - a prospective randomized 11-year follow-up.
    Pernaa K; Koski I; Mattila K; Gullichsen E; Heikkila J; Aho A; Lindfors N
    J Long Term Eff Med Implants; 2011; 21(2):139-48. PubMed ID: 22043972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BIOACTIVE GLASS S53P4: a new opportunity for the treatment in the diabetic foot osteomyelitis.
    De Giglio R; Stefani I; Mondello T; De Filippis G; Mazzone A
    Eur J Intern Med; 2018 Aug; 54():e15-e16. PubMed ID: 29709419
    [No Abstract]   [Full Text] [Related]  

  • 33. Sintered S53P4 bioactive glass scaffolds have anti-inflammatory properties and stimulate osteogenesis in vitro.
    Björkenheim R; Jämsen E; Eriksson E; Uppstu P; Aalto-Setälä L; Hupa L; Eklund KK; Ainola M; Lindfors NC; Pajarinen J
    Eur Cell Mater; 2021 Jan; 41():15-30. PubMed ID: 33389745
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Instrumented spondylodesis in degenerative spondylolisthesis with bioactive glass and autologous bone: a prospective 11-year follow-up.
    Frantzén J; Rantakokko J; Aro HT; Heinänen J; Kajander S; Gullichsen E; Kotilainen E; Lindfors NC
    J Spinal Disord Tech; 2011 Oct; 24(7):455-61. PubMed ID: 21909036
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vascularized fibular grafting in the treatment of methicillin-resistant Staphylococcus aureus osteomyelitis and infected nonunion.
    Yajima H; Kobata Y; Shigematsu K; Kawamura K; Kawate K; Tamai S; Takakura Y
    J Reconstr Microsurg; 2004 Jan; 20(1):13-20. PubMed ID: 14973770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bioactive glass S53P4 vs. autologous bone graft for filling defects in patients with chronic osteomyelitis and infected non-unions - a single center experience.
    Steinhausen E; Lefering R; Glombitza M; Brinkmann N; Vogel C; Mester B; Dudda M
    J Bone Jt Infect; 2021; 6(4):73-83. PubMed ID: 34084694
    [No Abstract]   [Full Text] [Related]  

  • 37. A prospective randomized 14-year follow-up study of bioactive glass and autogenous bone as bone graft substitutes in benign bone tumors.
    Lindfors NC; Koski I; Heikkilä JT; Mattila K; Aho AJ
    J Biomed Mater Res B Appl Biomater; 2010 Jul; 94(1):157-64. PubMed ID: 20524190
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bioactive glass, a new tool for the treatment in the diabetic foot recalcitrant osteomyelitis: A case series with 24-month follow-up.
    Rodríguez Á; Parra G; Cuervas-Mons M
    Foot (Edinb); 2021 Sep; 48():101831. PubMed ID: 34390944
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Injectable bioactive glass/biodegradable polymer composite for bone and cartilage reconstruction: concept and experimental outcome with thermoplastic composites of poly(epsilon-caprolactone-co-D,L-lactide) and bioactive glass S53P4.
    Aho AJ; Tirri T; Kukkonen J; Strandberg N; Rich J; Seppälä J; Yli-Urpo A
    J Mater Sci Mater Med; 2004 Oct; 15(10):1165-73. PubMed ID: 15516880
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resorption of the calcium phosphate layer on S53P4 bioactive glass by osteoclasts.
    van Gestel NAP; Schuiringa GH; Hennissen JHPH; Delsing ACA; Ito K; van Rietbergen B; Arts JJ; Hofmann S
    J Mater Sci Mater Med; 2019 Aug; 30(8):94. PubMed ID: 31414232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.